Technology
UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform
Computational advancements enable earlier and more widespread use of antibody-antigen structural insights across drug discovery process These advancements have the potential to transform antibody discovery methods, broadening therapeutic applications
By: prnewswire_apac
- Jan 09 2025
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS